Phase 3 study to evaluate the safety and effectiveness of LNZ101 compared with LNZ100 and Brimonidine for the treatment of Presbyopia.
Phase 3 study to evaluate the safety and effectiveness of LNZ101 for the treatment of Presbyopia.